Yes, GLP-1 agonists are generally considered safe for women, but its essential to consult with a healthcare professional to discuss any individual health concerns, medical history, or potential side effects
However, the same visualization advantages are not extended to non-surgeon personnel in the operating room, whose views are often compromised by glare or obstructed by equipment
In a summary analysis of multiple trials, it was found that "A lower energy intake was considered the key factor responsible for bodyweight reduction," meaning that a lower calorie intake was the most important factor in weight loss when taking obesity medicine
no causal association with neurodevelopmental disorders has been established, while untreated pain and fever can harm the mother and fetus
Include all supporting documentation and a cover letter addressing the specific denial reason
Risks During General Anesthesia and Deep Sedation GLP-1 agonists can delay gastric emptying, which can increase risk of regurgitation and pulmonary aspiration of gastric contents during general anesthesia and deep sedation
